Adiponectin in diabetes mellitus

Current Medicinal Chemistry

Volumn 19, Issue 32, 2012, Pages 5451-5458

  Xita, N ^a   Tsatsoulis, A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Adiponectin; Inflammation; Insulin resistance; Type 2 diabetes; Visceral adipocity

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ADIPONECTIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST;

ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENERGY EXPENDITURE; GLUCONEOGENESIS; HUMAN; HYPOADIPONECTINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; SIGNAL TRANSDUCTION;

ADIPONECTIN; ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY;

EID: 84870456778     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803833182     Document Type: Article

References (129)

1. Pajvani, U.B.; Du, X.; Combs, T.P.; Berg, A.H.; Rajala, M.W.; Schulthess, T.; Engel, J.; Brownlee, M.; Scherer, P.E. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J. Biol. Chem., 2003, 278, 9073-9085.
2. Lara-Castro, C.; Luo, N.; Wallace, P.; Klein, R.L.; Garvey, W.T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes., 2006, 55, 249-259.
3. Misra, M.; Miller, K.K.; Cord, J.; Prabhakaran, R.; Herzog, D.B.; Goldstein, M.; Katzman, D.K.; Klibanski, A. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J. Clin. Endocrinol. Metab., 2007, 92, 2046-2052.
4. Dunger, D.; Ong, K. Abundance of adiponectin in the newborn. Clin. Endocrinol. (Oxf)., 2004, 61, 416-417.
5. Fu, Y.; Luo, N.; Klein, R.L.; Garvey, W.T. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J. Lipid. Res., 2005, 46, 1369-1379.
6. Yamauchi, T.; Kamon, J.; Ito, Y.; Tsuchida, A.; Yokomizo, T.; Kita, S.; Sugiyama, T.; Miyagishi, M.; Hara, K.; Tsunoda, M.; Murakami, K.; Ohteki, T.; Uchida, S.; Takekawa, S.; Waki, H.; Tsuno, N.H.; Shibata, Y.; Terauchi, Y.; Froguel, P.; Tobe, K.; Koyasu, S.; Taira, K.; Kitamura, T.; Shimizu, T.; Nagai, R.; Kadowaki, T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature., 2003, 423, 762-769.
7. Hug, C.; Wang, J.; Ahmad, N.S.; Bogan, J.S.; Tsao, T.S.; Lodish, H.F. Tcadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc. Natl. Acad. Sci.USA., 2004, 101, 10308-10313.
8. Kadowaki, T.; Yamauchi, T.; Kubota, N.; Hara, K.; Ueki, K.; Tobe, K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest., 2006, 116, 1784-1792.
9. Yamauchi, T.; Nio, Y.; Maki, T.; Kobayashi, M.; Takazawa, T.; Iwabu, M.; Okada-Iwabu, M.; Kawamoto, S.; Kubota, N.; Kubota, T.; Ito, Y.; Kamon, J.; Tsuchida, A.; Kumagai, K.; Kozono, H.; Hada, Y.; Ogata, H.; Tokuyama, K.; Tsunoda, M.; Ide, T.; Murakami, K.; Awazawa, M.; Takamoto, I.; Froguel, P.; Hara, K.; Tobe, K.; Nagai, R.; Ueki, K.; Kadowaki, T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med., 2007, 13, 332-339.
10. Deepa, S.S.; Dong, L.Q. APPL1: role in adiponectin signaling and beyond. Am. J. Physiol. Endocrinol. Metab., 2009, 296, E22-36.
11. Mao, X.; Kikani, CK.; Riojas, R.A.; Langlais, P.; Wang, L.; Ramos, F.J.; Fang, Q.; Christ-Roberts, C.Y.; Hong, J.Y.; Kim, R.Y.; Liu, F.; Dong, L.Q. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell. Biol., 2006, 8, 516-523.
12. Kadowaki, T.; Yamauchi. T.; Kubota, N. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS. Letters., 2008, 582, 74-80.
13. Fiaschi, T.; Buricchi, F.; Cozzi, G.; Matthias, S.; Parri, M.; Raugei, G.; Ramponi, G.; Chiarugi, P. Redox-dependent and ligand-independent transactivation of insulin receptor by globular adiponectin. Hepatology., 2007, 46, 130-139.
14. Wang, C.; Mao, X.; Wang, L.; Liu, M.; Wetzel, M.D.; Guan, K.L.; Dong, L.Q.; Liu, F. Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J. Biol. Chem., 2007, 282, 7991-7996.
15. Awazawa, M.; Ueki, K.; Inabe, K.; Yamauchi, T.; Kubota, N.; Kaneko, K.; Kobayashi, M.; Iwane, A.; Sasako, T.; Okazaki, Y.; Ohsugi, M.; Takamoto, I.; Yamashita, S.; Asahara, H.; Akira, S.; Kasuga, M.; Kadowaki, T. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell. Metab., 2011, 13, 401-412.
16. Dietze-Schroeder, D.; Sell, H.; Uhlig, M.; Koenen, M.; Eckel, J. Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes., 2005, 54, 2003-2011.
17. Kharroubi, I.; Rasschaert, J.; Eizirik, D.L.; Cnop, M. Expression of adiponectin receptors in pancreatic beta cells. Biochem. Biophys. Res. Commun., 2003, 312, 1118-1122.
18. Okamoto, M.; Ohara-Imaizumi, M.; Kubota, N.; Hashimoto, S.; Eto, K.; Kanno, T.; Kubota, T.; Wakui, M.; Nagai, R.; Noda, M.; Nagamatsu, S.; Kadowaki, T. Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia., 2008, 51, 827-835.
19. Gu, W.; Li, X.; Liu, C.; Yang, J.; Ye, L.; Tang, J.; Gu, Y.; Yang, Y.; Hong, J.; Zhang, Y.; Chen, M.; Ning, G. Globular adiponectin augments insulin secretion from pancreatic islet beta cells at high glucose concentrations. Endocrine., 2006, 30, 217-221.
20. Winzell, M.S.; Nogueiras, R.; Dieguez, C.; Ahrén, B. Dual action of adiponectin on insulin secretion in insulin-resistant mice. Biochem. Biophys. Res. Commun., 2004, 321, 154-160.
21. Staiger, K.; Stefan, N.; Staiger, H.; Brendel, M.D.; Brandhorst, D.; Bretzel, R.G.; Machicao, F.; Kellerer, M.; Stumvoll, M.; Fritsche, A.; Häring, H.U. Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J. Clin. Endocrinol. Metab., 2005, 90, 6707-6713.
22. Wijesekara, N.; Krishnamurthy, M.; Bhattacharjee, A.; Suhail, A.; Sweeney, G.; Wheeler, M.B. Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion. J. Biol. Chem., 2010, 285, 33623-33631.
23. Rakatzi, I.; Mueller, H.; Ritzeler, O.; Tennagels, N.; Eckel, J. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia., 2004, 47, 249-258.
24. Holland, W.L.; Miller, R.A.; Wang, Z.V.; Sun, K.; Barth, B.M.; Bui, H.H.; Davis, K.E.; Bikman, B.T.; Halberg, N.; Rutkowski, J.M.; Wade, M.R.; Tenorio, V.M.; Kuo, M.S.; Brozinick, J.T.; Zhang, B.B.; Birnbaum, M.J.; Summers, S.A.; Scherer, P.E. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med., 2011, 17, 55-63.
25. Kusminski, C.M.; McTernan, P.G.; Schraw, T.; Kos, K.; O'Hare, J.P.; Ahima, R.; Kumar, S.; Scherer, P.E. Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia., 2007, 50, 634-642.
26. Ebinuma, H.; Miida, T.; Yamauchi, T.; Hada, Y.; Hara, K.; Kubota, N.; Kadowaki, T. Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid. Clin. Chem., 2007, 53, 1541-1544.
27. Qi, Y.; Takahashi, N.; Hileman, S.M.; Patel, H.R.; Berg, A.H.; Pajvani, U.B.; Scherer, P.E.; Ahima, R.S. Adiponectin acts in the brain to decrease body weight. Nat. Med., 2004, 10, 524-529.
28. Arita, Y.; Kihara, S.; Ouchi, N.; Takahashi, M.; Maeda, K.; Miyagawa, J.; Hotta, K.; Shimomura, I.; Nakamura, T.; Miyaoka, K.; Kuriyama, H.; Nishida, M.; Yamashita, S.; Okubo, K.; Matsubara, K.; Muraguchi, M.; Ohmoto, Y.; Funahashi, T.; Matsuzawa, Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 1999, 257, 79-83.
29. Cnop, M.; Havel, P.J.; Utzschneider, K.M.; Carr, D.B.; Sinha, M.K.; Boyko, E.J.; Retzlaff, B.M.; Knopp, R.H.; Brunzell, J.D.; Kahn, S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia., 2003, 46, 459-469.
30. Halleux, C.M.; Takahashi, M.; Delporte, M.L.; Detry, R.; Funahashi, T.; Matsuzawa, Y.; Brichard, S.M. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem. Biophys. Res. Commun., 2001, 288, 1102-1107.
31. Després, J.P., Golay, A.; Sjöström, L. Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med., 2005, 353, 2121- 2134.
32. Aguilar-Salinas, C.A., García, E.G.; Robles, L.; Riaño, D.; Ruiz-Gomez, D.G.; García-Ulloa, A.C.; Melgarejo, M.A.; Zamora, M.; Guillen-Pineda, L.E.; Mehta, R.; Canizales-Quinteros, S., Tusie Luna, M.T.; Gómez-Pérez, F.J. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J. Clin. Endocrinol. Metab., 2008, 93, 4075-4079.
33. Hyun, Y.J.; Koh, S.J.; Chae, J.S.; Kim, J.Y.; Kim, O.Y.; Lim, H.H.; Jang, Y.; Park, S.; Ordovas, J.M.; Lee, J.H. Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman. Obesity. (Silver Spring)., 2008, 16, 784-789.
34. Blüher, M. Adipose tissue dysfunction in obesity. Exp. Clin. Endocrinol. Diabetes., 2009, 117, 241-250.
35. Weyer, C.; Funahashi, T.; Tanaka, S.; Hotta, K.; Matsuzawa, Y.; Pratley, R.E.; Tataranni, P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab., 2001, 86, 1930-1935.
36. Hotta, K.; Funahashi, T.; Arita, Y.; Takahashi, M.; Matsuda, M.; Okamoto, Y.; Iwahashi, H.; Kuriyama, H.; Ouchi, N.; Maeda, K.; Nishida, M.; Kihara, S.; Sakai, N.; Nakajima, T.; Hasegawa, K.; Muraguchi, M.; Ohmoto, Y.; Nakamura, T.; Yamashita, S.; Hanafusa, T.; Matsuzawa, Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Bio., 2000, 20, 1595-1599.
37. Spranger, J.; Kroke, A.; Möhlig, M.; Bergmann, M.M.; Ristow, M.; Boeing, H.; Pfeiffer, A.F. Adiponectin and protection against type 2 diabetes mellitus. Lancet., 2003, 361, 226-228.
38. Lawlor, D.A.; Davey Smith, G.; Ebrahim, S.; Thompson, C.; Sattar, N. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J. Clin. Endocrinol. Metab., 2005, 90, 5677-5683.
39. Tschritter, O.; Fritsche, A.; Thamer, C.; Haap, M.; Shirkavand, F.; Rahe, S.; Staiger, H.; Maerker, E.; Häring, H.; Stumvoll, M. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes, 2003, 52, 239-243.
40. Hara, K.; Boutin, P.; Mori, Y.; Tobe, K.; Dina, C.; Yasuda, K.; Yamauchi, T.; Otabe, S.; Okada, T.; Eto, K.; Kadowaki, H.; Hagura, R.; Akanuma, Y.; Yazaki, Y.; Nagai, R.; Taniyama, M.; Matsubara, K.; Yoda, M.; Nakano, Y.; Tomita, M.; Kimura, S.; Ito, C.; Froguel, P.; Kadowaki, T. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes., 2002, 51, 536-540.
41. von Eynatten, M.; Humpert, P.M.; Bluemm, A.; Lepper, P.M.; Hamann, A.; Allolio, B.; Nawroth, P.P.; Bierhaus, A.; Dugi, K.A. High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis., 2008, 199, 123-128.
42. Heidemann, C.; Sun, Q.; van Dam, R.M.; Meigs, J.B.; Zhang, C.; Tworoger, S.S.; Mantzoros, C.; Hu, F.B. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann. Intern. Med., 2008, 149, 307-316.
43. Lindsay, R.S.; Funahashi, T.; Hanson, R.L.; Matsuzawa, Y.; Tanaka, S.; Tataranni, P.A.; Knowler, W.C.; Krakoff, J. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet., 2002, 360, 57-58.
44. Daimon, M.; Oizumi, T.; Saitoh, T.; Kameda, W.; Hirata, A.; Yamaguchi, H.; Ohnuma, H.; Igarashi, M.; Tominaga, M.; Kato, T.; Funagata study. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes. Care., 2003, 26, 2015-2020.
45. Snehalatha, C.; Mukesh, B.; Simon, M.; Viswanathan, V.; Haffner, S.M.; Ramachandran, A.; Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes. Care., 2003, 26, 3226-3229.
46. Yamamoto, Y.; Hirose, H.; Saito, I.; Nishikai, K.; Saruta, T. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year followup study in Japanese population. J. Clin. Endocrinol. Metab., 2004, 89, 87-90.
47. Choi, K.M.; Lee, J.; Lee, K.W.; Seo, J.A.; Oh, J.H.; Kim, S.G.; Kim, N.H.; Choi, D.S.; Baik, S.H. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin. Endocrinol., 2004, 61, 75-80.
48. Seino, Y.; Hirose, H.; Saito, I.; Itoh, H. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men. Metabolism., 2009, 58, 355-360.
49. Wannamethee, S.G.; Lowe, G.D.; Rumley, A.; Cherry, L.; Whincup, P.H.; Sattar, N.; Adipokines and risk of type 2 diabetes in older men. Diabetes. Care., 2007, 30, 1200-1205.
50. Mather, K.J.; Funahashi, T.; Matsuzawa, Y.; Edelstein, S.; Bray, G.A.; Kahn, S.E.; Crandall, J.; Marcovina, S.; Goldstein, B.; Goldberg, R.; Diabetes Prevention Program. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes., 2008, 57, 980-986.
51. Duncan, B.B.; Schmidt, M.I.; Pankow, J.S.; Bang, H.; Couper, D.; Ballantyne, C.M.; Hoogeveen, R.C.; Heiss, G. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes., 2004, 53, 2473- 2478.
52. Snijder, M.B.; Heine, R.J.; Seidell, J.C.; Bouter, L.M.; Stehouwer, C.D.; Nijpels, G.; Funahashi, T.; Matsuzawa, Y.; Shimomura, I.; Dekker, J.M. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn study. Diabetes. Care., 2006, 29, 2498-2503.
53. Li, S.; Shin, H.J.; Ding, E.L.; van Dam, R.M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA., 2009, 302, 179-188.
54. Kolberg, J.A.; Jørgensen, T.; Gerwien, R.W.; Hamren, S.; McKenna, M.P.; Moler, E.; Rowe, M.W.; Urdea, M.S.; Xu, X.M.; Hansen, T.; Pedersen, O.; Borch-Johnsen, K. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes. Care., 2009, 32, 1207-1212.
55. Kumada, M.; Kihara, S.; Sumitsuji, S.; Kawamoto, T.; Matsumoto, S.; Ouchi, N.; Arita, Y.; Okamoto, Y.; Shimomura, I.; Hiraoka, H.; Nakamura, T.; Funahashi, T.; Matsuzawa, Y.; Osaka CAD Study Group. Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 85-89.
56. Koenig, W.; Khuseyinova, N.; Baumert, J.; Meisinger, C.; Löwel, H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J. Am. Coll. Cardiol., 2006, 48, 1369-1377.
57. Schulze, M.B.; Shai, I.; Rimm, E.B.; Li, T.; Rifai, N.; Hu, F.B. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes., 2005, 54, 534-539.
58. Kato, K.; Osawa, H.; Ochi, M.; Kusunoki, Y.; Ebisui, O.; Ohno, K.; Ohashi, J.; Shimizu, I.; Fujii, Y.; Tanimoto, M.; Makino, H. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin. Endocrinol. (Oxf)., 2008, 68, 442-449.
59. Altinova, A.E.; Toruner, F.; Bozkurt, N.; Bukan, N.; Karakoc, A.; Yetkin, I.; Ayvaz, G.; Cakir, N.; Arslan, M. Circulating concentrations of adiponectin and tumor necrosis factor-alpha in gestational diabetes mellitus. Gynecol. Endocrinol., 2007, 23, 161-165.
60. Cortelazzi, D.; Corbetta, S.; Ronzoni, S.; Pelle, F.; Marconi, A.; Cozzi, V.; Cetin, I.; Cortelazzi, R.; Beck-Peccoz, P.; Spada, A. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin. Endocrinol. (Oxf)., 2007, 66, 447-453.
61. Kinalski, M.; Telejko, B.; Kuźmicki, M.; Kretowski, A.; Kinalska, I. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes. Horm, Metab, Res, 2005, 37, 450-454.
62. Mazaki-Tovi, S.; Romero, R.; Vaisbuch, E.; Erez, O.; Mittal, P.; Chaiworapongsa, T.; Kim, S.K.; Pacora, P.; Yeo, L.; Gotsch, F.; Dong, Z.; Yoon, B.H.; Hassan, S.S.; Kusanovic, J.P. Maternal serum adiponectin multimers in gestational diabetes. J. Perinat. Med., 2009, 37, 637-650.
63. Ranheim, T.; Haugen, F.; Staff, A.C.; Braekke, K.; Harsem, N.K.; Drevon, C.A. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta. Obstet. Gynecol. Scand., 2004, 83, 341-347.
64. Retnakaran, R.; Hanley, A.J.; Raif, N.; Connelly, P.W.; Sermer, M.; Zinman, B. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes. Care., 2004, 27, 799-800.
65. Lain, K.Y.; Daftary, A.R.; Ness, R.B.; Roberts, J.M. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin. Endocrinol. (Oxf)., 2008, 69, 407-411.
66. Williams, M.A.; Qiu, C.; Muy-Rivera, M.; Vadachkoria, S.; Song, T.; Luthy, D.A. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J. Clin. Endocrinol. Metab., 2004, 89, 2306-2311.
67. Vitoratos, N.; Deliveliotou, A.; Vlahos, N.F.; Mastorakos, G.; Papadias, K.; Botsis, D.; Creatsas, G.K. Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecol. Endocrinol., 2008, 24, 614-619.
68. Winzer, C.; Wagner, O.; Festa, A.; Schneider, B.; Roden, M.; Bancher-Todesca, D.; Pacini, G.; Funahashi, T.; Kautzky-Willer, A. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes. Care., 2004, 27, 1721-1727.
69. Lindsay, R.S.; Walker, J.D.; Havel, P.J.; Hamilton, B.A.; Calder, A.A.; Johnstone, F.D.; Scottish Multicentre Study of Diabetes Pregnancy. Adiponectin is present in cord blood but is unrelated to birth weight. Diabetes. Care., 2003, 26, 2244-2249.
70. Galler, A.; Gelbrich, G.; Kratzsch, J.; Noack, N.; Kapellen, T.; Kiess, W. Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study. Eur. J. Endocrinol., 2007, 157, 481-489.
71. Perseghin, G.; Lattuada, G.; Danna, M.; Sereni, L.P.; Maffi, P.; De Cobelli, F.; Battezzati, A.; Secchi, A.; Del Maschio, A.; Luzi, L. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am. J. Physiol. Endocrinol. Metab., 2003, 285, E1174-1181.
72. Heilman, K.; Zilmer, M.; Zilmer, K.; Kool, P.; Tillmann, V. Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes. Scand. J. Clin. Lab. Invest., 2009, 69, 85-91.
73. Barnes, M.M.; Curran-Everett, D.; Hamman, R.F.; Maahs, D.; Mayer-Davis, E.J.; D'Agostino, R.B.Jr.; West, N.; Dabelea, D. Determinants of adiponectin levels in young people with Type 1 diabetes. Diabet. Med., 2008, 25, 365-369.
74. Imagawa, A.; Funahashi, T.; Nakamura, T.; Moriwaki, M.; Tanaka, S.; Nishizawa, H.; Sayama, K.; Uno, S.; Iwahashi, H.; Yamagata, K.; Miyagawa, J.; Matsuzawa, Y. Elevated serum concentration of adiposederived factor, adiponectin, in patients with type 1 diabetes. Diabetes. Care., 2002, 25, 1665-1666.
75. Hadjadj, S.; Aubert, R.; Fumeron, F.; Pean, F.; Tichet, J.; Roussel, R.; Marre, M.; SURGENE Study Group.; DESIR Study Group. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects. Diabetologia, 2005, 48, 1088-1092.
76. Richards, A.A.; Stephens, T.; Charlton, H.K.; Jones, A.; Macdonald, G.A.; Prins, J.B.; Whitehead, J.P. Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications. Mol. Endocrinol., 2006, 20, 1673-1687.
77. Sharma, K.; Ramachandrarao, S.; Qiu, G.; Usui, H.K.; Zhu, Y.; Dunn, S.R.; Ouedraogo, R.; Hough, K.; McCue, P.; Chan, L.; Falkner, B.; Goldstein, B.J. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest., 2008, 118, 1645-1656.
78. Kubota, N.; Terauchi, Y.; Yamauchi, T.; Kubota, T.; Moroi, M.; Matsui, J.; Eto, K.; Yamashita, T.; Kamon, J.; Satoh, H.; Yano, W.; Froguel, P.; Nagai, R.; Kimura, S.; Kadowaki, T.; Noda, T. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem., 2002, 277, 25863-25866.
79. Maeda, N.; Shimomura, I.; Kishida, K.; Nishizawa, H.; Matsuda, M.; Nagaretani, H.; Furuyama, N.; Kondo, H.; Takahashi, M.; Arita, Y.; Komuro, R.; Ouchi, N.; Kihara, S.; Tochino, Y.; Okutomi, K.; Horie, M.; Takeda, S.; Aoyama, T.; Funahashi, T.; Matsuzawa, Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med., 2002, 8, 731-737.
80. Yamauchi, T.; Nio, Y.; Maki, T.; Kobayashi, M.; Takazawa, T.; Iwabu, M.; Okada-Iwabu, M.; Kawamoto, S.; Kubota, N.; Kubota, T.; Ito, Y.; Kamon, J.; Tsuchida, A.; Kumagai, K.; Kozono, H.; Hada, Y.; Ogata, H.; Tokuyama, K.; Tsunoda, M.; Ide, T.; Murakami, K.; Awazawa, M.; Takamoto, I.; Froguel, P.; Hara, K.; Tobe, K.; Nagai, R.; Ueki, K.; Kadowaki, T. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med., 2007, 13, 332-339.
81. Yamauchi, T.; Kamon, J.; Waki, H.; Terauchi, Y.; Kubota, N.; Hara, K.; Mori, Y.; Ide, T.; Murakami, K.; Tsuboyama-Kasaoka, N.; Ezaki, O.; Akanuma, Y.; Gavrilova, O.; Vinson, C.; Reitman, M.L.; Kagechika, H.; Shudo, K.; Yoda, M.; Nakano, Y.; Tobe, K.; Nagai, R.; Kimura, S.; Tomita, M.; Froguel, P.; Kadowaki, T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med., 2001, 7, 941-946.
82. Berg, A.H.; Combs, T.P.; Du, X.; Brownlee, M.; Scherer, P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med., 2001, 7, 947-953.
83. Combs, T.P.; Berg, A.H.; Obici, S.; Scherer, P.E.; Rossetti, L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest., 2001, 108, 1875-1881.
84. Fruebis, J.; Tsao, T.S.; Javorschi, S.; Ebbets-Reed, D.; Erickson, M.R.; Yen, F.T.; Bihain, B.E.; Lodish, H.F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA., 2001, 98, 2005-2010.
85. Hotta, K.; Funahashi, T.; Bodkin, N.L.; Ortmeyer, H.K.; Arita, Y.; Hansen, B.C.; Matsuzawa, Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes., 2001, 50, 1126-1133.
86. Butte, N.F.; Comuzzie, A.G.; Cai, G.; Cole, S.A.; Mehta, N.R.; Bacino, C.A. Genetic and environmental factors influencing fasting serum adiponectin in Hispanic children. J. Clin. Endocrinol. Metab., 2005, 90, 4170-4176.
87. Vasseur, F.; Helbecque, N.; Dina, C.; Lobbens, S.; Delannoy, V.; Gaget, S.; Boutin, P.; Vaxillaire, M.; Leprêtre, F.; Dupont, S.; Hara, K.; Clément, K.; Bihain, B.; Kadowaki, T.; Froguel, P. Single-nucleotide polymorphism haplotypes in the both proximal promotor and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum. Mol. Genet., 2002, 11, 2607-2614.
88. Pollin, T.I.; Tanner, K.; O'Connell, J.R.; Ott, S.H.; Damcott, C.M.; Shuldiner, A.R.; McLenithan, J.C.; Mitchell, B.D. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes., 2005, 54, 268-274.
89. Kissebah, A.H.; Sonnenberg, G.E.; Myklebust, J.; Goldstein, M.; Broman, K.; James, R.G.; Marks, J.A.; Krakower, G.R.; Jacob, H.J.; Weber, J.; Martin, L.; Blangero, J.; Comuzzie, A.G. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. USA., 2000, 97, 14478-14483.
90. Vionnet, N.; Hani, E.H.; Dupont, S.; Gallina, S.; Francke, S.; Dotte, S.; De Matos, F.; Durand, E.; Leprêtre, F.; Lecoeur, C.; Gallina, P.; Zekiri, L.; Dina, C.; Froguel, P. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet., 2000, 67, 1470-1480.
91. Francke, S.; Manraj, M.; Lacquemant, C.; Lecoeur, C.; Lepretre, F.; Passa, P.; Hebe, A.; Corset, L.; Yan, S.L.; Lahmidi, S.; Jankee, S.; Gunness, T.K.; Ramjuttun, U.S.; Balgobin, V.; Dina, C.; Froguel, P. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum. Mol. Genet., 2001, 10, 2751-2765.
92. Mori, Y.; Otabe, S.; Dina, C.; Yasuda, K.; Populaire, C.; Lecoeur, C.; Vatin, V.; Durand, E.; Hara, K.; Okada, T.; Tobe, K.; Boutin, P.; Kadowaki, T.; Froguel, P. Genome-wide search for type 2 diabetes in Japanese affected sibpairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes., 2002, 51, 1247-1255.
93. Waki, H.; Yamauchi, T.; Kamon, J.; Ito, Y.; Uchida, S.; Kita, S.; Hara, K.; Hada, Y.; Vasseur, F.; Froguel, P.; Kimura, S.; Nagai, R.; Kadowaki, T. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J. Biol. Chem., 2003, 278, 40352-40363.
94. Menzaghi, C.; Ercolino, T.; Di Paola, R.; Berg, A.H.; Warram, J.H.; Scherer, P.E.; Trischitta, V.; Doria, A. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes., 2002, 51, 2306-2312.
95. Stumvoll, M.; Tschritter, O.; Fritsche, A.; Staiger, H.; Renn, W.; Weisser, M.; Machicao, F.; Haring, H. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes., 2002, 51, 37-41.
96. Ukkola, O.; Ravussin, E.; Jacobson, P.; Sjöström, L.; Bouchard, C.; Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism., 2003, 52, 881-884.
97. Qi, L.; Doria, A.; Manson, J.E.; Meigs, J.B.; Hunter, D.; Mantzoros, C.S.; Hu, F.B. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes., 2006, 55, 1512-1516.
98. Tankó, L.B.; Siddiq, A.; Lecoeur, C.; Larsen, P.J.; Christiansen, C.; Walley, A.; Froguel, P. ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity. Obes. Res., 2005, 13, 2113-2121.
99. Yang, W.S.; Chuang, L.M. Human genetics of adiponectin in the metabolic syndrome. J. Mol. Med. (Berl)., 2006, 84, 112-121.
100. Jang, Y.; Chae, J.S.; Koh, S.J.; Hyun, Y.J.; Kim, J.Y.; Jeong, Y.J.; Park, S.; Ahn, C.M.; Lee, J.H. The influence of the adiponectin gene on adiponectin concentrations and parameters of metabolic syndrome in non-diabetic Korean women. Clin. Chim. Acta., 2008, 391, 85-90.
101. Menzaghi, C.; Trischitta, V.; Doria, A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes., 2007, 56, 1198-1209.
102. Bouatia-Naji, N.; Meyre, D.; Lobbens, S.; Séron, K.; Fumeron, F.; Balkau, B.; Heude, B.; Jouret, B.; Scherer, P.E.; Dina, C.; Weill, J.; Froguel, P. ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity. Diabetes., 2006, 55, 545-550.
103. Han, L.Y.; Wu, Q.H.; Jiao, M.L.; Hao, Y.H.; Liang, L.B.; Gao, L.J.; Legge, D.G.; Quan, H.; Zhao, M.M.; Ning, N.; Kang, Z.; Sun, H. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, - 11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia., 2011, 54, 2303-2314.
104. Civitarese, A.E.; Jenkinson, C.P.; Richardson, D.; Bajaj, M.; Cusi, K.; Kashyap, S.; Berria, R.; Belfort, R.; DeFronzo, R.A.; Mandarino, L.J.; Ravussin, E. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of type 2 diabetes. Diabetologia., 2004, 47, 816-820.
105. Debard, C.; Laville, M.; Berbe, V.; Loizon, E.; Guillet, C.; Morio-Liondore, B.; Boirie, Y.; Vidal, H. Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of type 2 diabetic patients. Diabetologia., 2004, 47, 917-925.
106. Siitonen, N.; Pulkkinen, L.; Mager, U.; Lindström, J.; Eriksson, J.G.; Valle, T.T.; Hämäläinen, H.; Ilanne-Parikka, P.; Keinänen-Kiukaanniemi, S.; Tuomilehto, J.; Laakso, M.; Uusitupa, M. Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study. Diabetologia., 2006, 49, 1795-1805.
107. Damcott, C.M.; Ott, S.H.; Pollin, T.I.; Reinhart, L.J.; Wang, J.; O'connell, J.R.; Mitchell, B.D.; Shuldiner, A.R. Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish. Diabetes., 2005, 54, 2245-2250.
108. Potapov, V.A.; Chistiakov, D.A.; Dubinina, A.; Shamkhalova, M.S.; Shestakova, M.V.; Nosikov, V.V. Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. Rev. Diabet. Stud., 2008, 5, 28-37.
109. Rasmussen-Torvik, L.J.; Pankow, J.S.; Jacobs, D.R.Jr.; Steinberger, J.; Moran, A.; Sinaiko, A.R. The association of SNPs in ADIPOQ, ADIPOR1, and ADIPOR2 with insulin sensitivity in a cohort of adolescents and their parents. Hum. Genet., 2009, 125, 21-28.
110. Vaxillaire, M.; Dechaume, A.; Vasseur-Delannoy, V.; Lahmidi, S.; Vatin, V.; Lepretre, F.; Boutin, P.; Hercberg, S.; Charpentier, G.; Dina, C.; Froguel, P. Genetic Analysis of ADIPOR1 and ADIPOR2 Candidate Polymorphisms for Type 2 Diabetes in the Caucasian Population. Diabetes., 2006, 55, 856-861.
111. Liao, Y.F.; Chen, L.L.; Zeng, T.S.; Zheng, J.; Li, H.Q. Association of the +33371 A/G polymorphism in adiponectin receptor 2 gene with Type 2 diabetes in the Chinese population. J. Endocrinol. Invest., 2007, 30, 860-864.
112. Siitonen, N.; Pulkkinen, L.; Lindström, J.; Kolehmainen, M.; Schwab, U.; Eriksson, J.G.; Ilanne-Parikka, P.; Keinänen-Kiukaanniemi, S.; Tuomilehto, J.; Uusitupa, M. Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study. Cardiovasc. Diabetol., 2011, 10, 83.
113. Fasshauer, M.; Klein, J.; Neumann, S.; Eszlinger, M.; Paschke, R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun., 2002, 290, 1084-1089.
114. Skurk, T.; Alberti-Huber, C.; Herder, C.; Hauner, H. Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab., 2007, 92, 1023-1033.
115. Ye, J.; Gao, Z.; Yin, J.; He, Q. Hypoxia is a potential risk factor for chronic infammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab., 2007, 293, E1118-1128.
116. Maeda, N.; Takahashi, M.; Funahashi, T.; Kihara, S.; Nishizawa, H.; Kishida, K.; Nagaretani, H.; Matsuda, M.; Komuro, R.; Ouchi, N.; Kuriyama, H.; Hotta, K.; Nakamura, T.; Shimomura, I.; Matsuzawa, Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes., 2001, 50, 2094-2099.
117. Yu, J.G.; Javorschi, S.; Hevener, A.L.; Kruszynska, Y.T.; Norman, R.A.; Sinha, M.; Olefsky, J.M. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes., 2002, 51, 2968-2974.
118. Hirose, H.; Kawai, T.; Yamamoto, Y.; Taniyama, M.; Tomita, M.; Matsubara, K.; Okazaki, Y.; Ishii, T.; Oguma, Y.; Takei, I.; Saruta T. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism., 2002, 51, 314-317.
119. Okuno, A.; Tamemoto, H.; Tobe, K.; Ueki, K.; Mori, Y.; Iwamoto, K.; Umesono, K.; Akanuma, Y.; Fujiwara, T.; Horikoshi, H.; Yazaki, Y.; Kadowaki, T. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest., 1998, 101, 1354-1361.
120. Kubota, N.; Terauchi, Y.; Miki, H.; Tamemoto, H.; Yamauchi, T.; Komeda, K.; Satoh, S.; Nakano, R.; Ishii, C.; Sugiyama, T.; Eto, K.; Tsubamotom Y.; Okuno, A.; Murakami, K.; Sekihara, H.; Hasegawa, G.; Naito, M.; Toyoshima, Y.; Tanaka, S.; Shiota, K.; Kitamura, T.; Fujita, T.; Ezaki, O.; Aizawa, S.; Kadowaki, T. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell., 1999, 4, 597-609.
121. Yamauchi, T.; Kamon, J.; Waki, H.; Murakami, K.; Motojima, K.; Komeda, K.; Ide, T.; Kubota, N.; Terauchi, Y.; Tobe, K.; Miki, H.; Tsuchida, A.;, Akanuma, Y.; Nagai, R.; Kimura, S.; Kadowaki, T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J. Biol. Chem., 2001, 276, 41245-41254.
122. Iwaki, M.; Matsuda, M.; Maeda, N.; Funahashi, T.; Matsuzawa, Y.; Makishima, M.; Shimomura, I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes., 2003, 52, 1655-1663.
123. Phillips, S.A.; Kung, J.; Ciaraldi, T.P.; Choe, C.; Christiansen, L.; Mudaliar, S.; Henry, R.R. Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans. Am. J. Physiol. Endocrinol. Metab., 2009, 297, E767-773.
124. Nawrocki, A.R.; Rajala, M.W.; Tomas, E.; Pajvani, U.B.; Saha, A.K.; Trumbauer, M.E.; Pang, Z.; Chen, A.S.; Ruderman, N.B.; Chen, H.; Rossetti, L.; Scherer, P.E. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem., 2006, 281, 2654-2660.
125. Hiuge, A.; Tenenbaum, A.; Maeda, N.; Benderly, M.; Kumada, M.; Fisman, E.Z.; Tanne, D.; Matas, Z.; Hibuse, T.; Fujita, K.; Nishizawa, H.; Adler, Y.; Motro, M.; Kihara, S.; Shimomura, I.; Behar, S.; Funahashi, T. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Arterioscler. Thromb. Vasc. Biol., 2007, 27, 635-641.
126. Rosenson, R.S. Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients. Obesity. (Silver Spring)., 2009, 17, 504-509.
127. Chinetti, G.; Zawadski, C.; Fruchart, J.C.; Staels, B. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem. Biophys. Res. Commun., 2004, 314, 151-158.
128. Clasen, R.; Schupp, M.; Foryst-Ludwig, A.; Sprang, C.; Clemenz, M.; Krikov, M.; Thöne-Reineke, C.; Unger, T.; Kintscher, U. PPARgamma activating angiotensin type-1 receptor blockers induce adiponectin. Hypertension., 2005, 46, 137-143.
129. Furuhashi, M.; Ura, N.; Higashiura, K.; Murakami, H.; Tanaka, M.; Moniwa, N.; Yoshida, D.; Shimamoto, K. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension., 2003, 42, 76-81.